Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bitran

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|April 1, 1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluationD S Ettinger, J D Bitran, R L Comis, et al.
British Journal of Cancer|July 19, 2012
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancerC Nabhan, D Villines, T V Valdez, et al.
Cancer|January 1, 1977
Survival of patients with localized histiocytic lymphomaJ D Bitran, J Kinzie, D L Sweet, et al.
Cancer Treatment Reports|September 1, 1976
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T R DeMeester, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.
Seminars in Oncology|October 1, 1994
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.
Journal of Surgical Oncology|January 1, 1983
Multimodality therapy of stage III adenocarcinoma of the breastJ D Bitran, R K Desser, D Schifeling, et al.
The Cancer Journal From Scientific American|November 1, 1995
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancerG A Masters, L C Drinkard, P C Hoffman, et al.
Cancer Treatment Reports|March 1, 1978
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T DeMeester, et al.
Cancer|July 1, 1984
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experienceP J Madej, J D Bitran, H M Golomb, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|April 1, 1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluationD S Ettinger, J D Bitran, R L Comis, et al.
British Journal of Cancer|July 19, 2012
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancerC Nabhan, D Villines, T V Valdez, et al.
Cancer|January 1, 1977
Survival of patients with localized histiocytic lymphomaJ D Bitran, J Kinzie, D L Sweet, et al.
Cancer Treatment Reports|September 1, 1976
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T R DeMeester, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.
Seminars in Oncology|October 1, 1994
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.
Journal of Surgical Oncology|January 1, 1983
Multimodality therapy of stage III adenocarcinoma of the breastJ D Bitran, R K Desser, D Schifeling, et al.
The Cancer Journal From Scientific American|November 1, 1995
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancerG A Masters, L C Drinkard, P C Hoffman, et al.
Cancer Treatment Reports|March 1, 1978
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinomaJ D Bitran, R K Desser, T DeMeester, et al.
Cancer|July 1, 1984
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experienceP J Madej, J D Bitran, H M Golomb, et al.
Pageof 20